May 13, 2020 / 12:19 PM / 21 days ago

BRIEF-Mersana Therapeutics To Report Interim Data From Phase 1 Dose Expansion of XMT-1536

May 13 (Reuters) - Mersana Therapeutics Inc:

* MERSANA THERAPEUTICS TO REPORT INTERIM DATA FROM PHASE 1 DOSE EXPANSION OF XMT-1536 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below